Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT01184300
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
200
Enrollment(s)
1
Study location(s)
Interventional (Phase II|Phase III)
Stable Coronary Artery Disease
Acute Coronary Syndrome
Percutaneous Coronary Intervention
Completed
NCT00171015
VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
212
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT00830960
A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
720
Enrollment(s)
19
Study location(s)
Interventional (Phase III)
Acute Coronary Syndrome
Completed
NCT01346800
Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers
10
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Healthy Volunteers
Completed
NCT01338909
Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)
35
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Myocardial Infarction
Unknown status
NCT01427127
Effect of Ramosetron on Bowel Motility After Colorectal Resection
64
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Postoperative Nausea and Vomiting
Terminated
NCT00402376
Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy
20
Enrollment(s)
2
Study location(s)
Interventional (Phase IV)
Heart Failure
Completed
NCT01304472
Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment
25
Enrollment(s)
2
Study location(s)
Interventional (Phase III)
Coronary Artery Disease (CAD)
96
97
98
99
100